[go: up one dir, main page]

DE60016231D1 - Streptomyces avermitilis gen zum regulieren des verhältnisses der b2:b1 avermectinen - Google Patents

Streptomyces avermitilis gen zum regulieren des verhältnisses der b2:b1 avermectinen

Info

Publication number
DE60016231D1
DE60016231D1 DE60016231T DE60016231T DE60016231D1 DE 60016231 D1 DE60016231 D1 DE 60016231D1 DE 60016231 T DE60016231 T DE 60016231T DE 60016231 T DE60016231 T DE 60016231T DE 60016231 D1 DE60016231 D1 DE 60016231D1
Authority
DE
Germany
Prior art keywords
avermectins
gen
regulating
relationship
streptomyces avermitilis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60016231T
Other languages
English (en)
Other versions
DE60016231T2 (de
Inventor
Kim Jonelle Stutzman-Engwall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Application granted granted Critical
Publication of DE60016231D1 publication Critical patent/DE60016231D1/de
Publication of DE60016231T2 publication Critical patent/DE60016231T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C12P19/623—Avermectin; Milbemycin; Ivermectin; C-076

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60016231T 1999-08-12 2000-07-19 Streptomyces avermitilis gen zum regulieren des verhältnisses der b2:b1 avermectinen Expired - Fee Related DE60016231T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/372,934 US6248579B1 (en) 1998-02-13 1999-08-12 Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins
US372934 1999-08-12
PCT/IB2000/000996 WO2001012822A1 (en) 1999-08-12 2000-07-19 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins

Publications (2)

Publication Number Publication Date
DE60016231D1 true DE60016231D1 (de) 2004-12-30
DE60016231T2 DE60016231T2 (de) 2005-12-08

Family

ID=23470234

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60016231T Expired - Fee Related DE60016231T2 (de) 1999-08-12 2000-07-19 Streptomyces avermitilis gen zum regulieren des verhältnisses der b2:b1 avermectinen

Country Status (37)

Country Link
US (8) US6248579B1 (de)
EP (1) EP1200605B1 (de)
JP (2) JP3688640B2 (de)
KR (1) KR100486006B1 (de)
CN (1) CN1186447C (de)
AP (2) AP2002002419A0 (de)
AR (1) AR021450A1 (de)
AT (1) ATE283363T1 (de)
AU (1) AU779756B2 (de)
BG (1) BG106478A (de)
BR (1) BR0013093A (de)
CA (1) CA2381427A1 (de)
CO (1) CO5290296A1 (de)
CZ (1) CZ2002297A3 (de)
DE (1) DE60016231T2 (de)
EA (1) EA004569B1 (de)
ES (1) ES2231214T3 (de)
GT (2) GT200000138A (de)
HK (1) HK1046536B (de)
HR (1) HRP20020131A2 (de)
HU (1) HUP0202517A2 (de)
IL (1) IL147562A0 (de)
IS (1) IS6249A (de)
MA (1) MA26811A1 (de)
MX (1) MXPA02001514A (de)
NO (1) NO20020665D0 (de)
OA (1) OA11997A (de)
PA (1) PA8499201A1 (de)
PE (1) PE20010697A1 (de)
PL (1) PL353770A1 (de)
PT (1) PT1200605E (de)
SK (1) SK1382002A3 (de)
TN (1) TNSN00170A1 (de)
UY (1) UY26287A1 (de)
WO (1) WO2001012822A1 (de)
YU (1) YU8402A (de)
ZA (1) ZA200201071B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001012821A1 (en) * 1999-08-12 2001-02-22 Pfizer Products Inc. Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
EP1474396B9 (de) 2002-02-05 2008-07-09 Bristol-Myers Squibb Company N-substituierte 3-hydroxy-4-pyridinone und diese enthaltende pharmazeutika
JP2005517406A (ja) 2002-02-12 2005-06-16 ファイザー・プロダクツ・インク Ｂ２：Ｂ１アベルメクチン比を支配するＳｔｒｅｐｔｏｍｙｃｅｓａｖｅｒｍｉｔｉｌｉｓ遺伝子
US7943160B2 (en) * 2002-05-09 2011-05-17 Scimetrics Limited Corp. Pest control methods
WO2004067549A2 (de) * 2003-01-31 2004-08-12 Max-Delbrück-Centrum für Molekulare Medizin Peptide gegen kälteunverträglichkeit hervorrufende autoantikörper und ihre verwendung
KR100759130B1 (ko) 2005-02-12 2007-09-19 휴메드 주식회사 항 인테그린 항체 코팅스텐트 및 그의 제조방법
CN106148216B (zh) 2015-03-27 2019-06-04 浙江海正药业股份有限公司 一种链霉菌及其生产米尔贝霉素a3的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5525506A (en) 1987-01-23 1996-06-11 Pfizer Inc. Process for production of avermectins and cultures therefor
US5234831A (en) 1987-01-23 1993-08-10 Pfizer Inc Cultures for production of B avermectins
US5238848A (en) 1987-01-23 1993-08-24 Pfizer Inc Cultures for production of avermectins
US5240850A (en) 1987-10-23 1993-08-31 Pfizer Inc. Cultures for production of avermectin aglycones
ES2054822T3 (es) 1987-10-23 1994-08-16 Pfizer Procedimiento para la produccion de agliconas de avermectinas y sus cultivos.
US5252474A (en) 1989-03-31 1993-10-12 Merck & Co., Inc. Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use
ATE129286T1 (de) 1989-03-31 1995-11-15 Merck & Co Inc Klonierung von streptomyces avermitilis genen zur biosynthese von avermectin und verfahren zu ihrer verwendung.
AU6657294A (en) 1993-07-30 1995-02-28 Pfizer Inc. Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis
CN1040113C (zh) * 1993-10-05 1998-10-07 美国辉瑞有限公司 抗寄生虫药物多哇麦汀(doramectin)的中间体及其制备方法
FI942725L (fi) 1993-12-16 1995-06-17 Pfizer Haaraketjuista alfaketohappodenydrogenaasikompleksia koodaavia geenejä Streptomyces avermitiliksesta
HUP0100784A3 (en) * 1998-02-13 2004-10-28 Pfizer Prod Inc Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins

Also Published As

Publication number Publication date
JP2003507018A (ja) 2003-02-25
EP1200605A1 (de) 2002-05-02
CZ2002297A3 (cs) 2002-08-14
PL353770A1 (en) 2003-12-01
IL147562A0 (en) 2002-08-14
TNSN00170A1 (fr) 2005-11-10
JP3688640B2 (ja) 2005-08-31
US6511841B2 (en) 2003-01-28
HRP20020131A2 (en) 2003-12-31
BR0013093A (pt) 2002-08-13
PT1200605E (pt) 2005-04-29
AU779756B2 (en) 2005-02-10
DE60016231T2 (de) 2005-12-08
HUP0202517A2 (hu) 2002-11-28
SK1382002A3 (en) 2002-11-06
EA004569B1 (ru) 2004-06-24
US20050196777A1 (en) 2005-09-08
BG106478A (bg) 2004-02-27
KR100486006B1 (ko) 2005-05-03
ATE283363T1 (de) 2004-12-15
CN1370239A (zh) 2002-09-18
AP2002002419A0 (en) 2002-03-31
US6833263B2 (en) 2004-12-21
YU8402A (sh) 2006-03-03
CN1186447C (zh) 2005-01-26
US20030134313A1 (en) 2003-07-17
WO2001012822A1 (en) 2001-02-22
NO20020665L (no) 2002-02-11
AU5702100A (en) 2001-03-13
ZA200201071B (en) 2003-06-25
UY26287A1 (es) 2001-03-16
PE20010697A1 (es) 2001-07-05
KR20020022809A (ko) 2002-03-27
HK1046536A1 (en) 2003-01-17
GT200000138CA (es) 2002-02-02
US7029887B2 (en) 2006-04-18
US20030129636A1 (en) 2003-07-10
AR021450A1 (es) 2002-07-17
US20030124607A1 (en) 2003-07-03
EP1200605B1 (de) 2004-11-24
EA200200057A1 (ru) 2002-06-27
MXPA02001514A (es) 2002-07-02
US7259241B2 (en) 2007-08-21
HK1046536B (zh) 2005-05-13
IS6249A (is) 2002-01-25
PA8499201A1 (es) 2001-12-14
US6248579B1 (en) 2001-06-19
US20030129635A1 (en) 2003-07-10
MA26811A1 (fr) 2004-12-20
AP2002002417A0 (en) 2002-03-31
CA2381427A1 (en) 2001-02-22
ES2231214T3 (es) 2005-05-16
US6509159B2 (en) 2003-01-21
US20010024818A1 (en) 2001-09-27
GT200000138A (es) 2002-02-02
OA11997A (en) 2006-04-18
NO20020665D0 (no) 2002-02-11
CO5290296A1 (es) 2003-06-27
US20010016350A1 (en) 2001-08-23
JP2005198658A (ja) 2005-07-28

Similar Documents

Publication Publication Date Title
MXPA03001775A (es) Derivados de nucleosidos.
ZA200204379B (en) N6 heterocyclic 8-modified adenosine derivatives.
NO20020684L (no) 3(5)-aminopyrazolderivater, fremgangsmåtet for deres fremstilling og deres anvendelse som antitumormidler
MX237254B (es) Inhibidores sglt2 de glucosidos c-arilo.
HRP20030306A2 (en) Pyridine derivatives with ikb-kinase (ikk-?) inhibiting activity
HK1034978A1 (en) Adenosine derivatives.
HUP0203707A3 (en) Oligosaccharide mixture
DE60040168D1 (de) Fluorelastomer-zusammensetzung zum vernetzen
SI1165495T1 (en) Resorcinol derivatives
HUP0303533A3 (en) Adenosine a1 agonist adenosine derivatives
AU4498201A (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment ofpain
DE60016231D1 (de) Streptomyces avermitilis gen zum regulieren des verhältnisses der b2:b1 avermectinen
AU3167402A (en) Aminotriazolopyridiine derivatives as adenosine receptor ligands
AU2003293635A8 (en) 4'' - modified erythromycin derivatives
DE60031126D1 (de) Streptomyces avermitilis gen zum regulieren des verhältnisses der b2:b1 avermectinen
DE60039998D1 (de) Pentacyclische taxan-verbindungen
ATE426659T1 (de) Streptomyces avermitilis gen zur regulierung des verhaltnisses der b2:b1 avermectine
AU2002215965A1 (en) Pyranoside derivatives
EP1295891A4 (de) Nukleosidderivate
TW375068U (en) Improved structure for the spanner
GB0021285D0 (en) Nucleoside derivatives
GB0026611D0 (en) Nucleoside derivatives
DK1200605T3 (da) Streptomyces avermitilis gen, der dirigerer forholdet imellem B2:B1 avermectiner
PL342404A1 (en) Nucleosides

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee